'Hard to lose' mutations in tumors may predict response to immunotherapy
byJohns Hopkins University School of MedicineThe figure shows the interactions between immune cells (white) and tumor cells harboring persistent mutations (red) in the context of immunotherapy (
Updated on: January 22,2024
12

'Hard to lose' mutations in tumors may predict response to immunotherapy
byJohns Hopkins University School of MedicineThe figure shows the interactions between immune cells (white) and tumor cells harboring persistent mutations (red) in the context of immunotherapy (
Updated on:January 22,2024
12
